Risk factor
Meaningful price volatility
Profitability factor
Greatly overvalued vs peers
About
Hainan Haiyao Co., Ltd. is a pharmaceutical and medical device company with a global presence, engaged in both the production and distribution of its offerings. The company's comprehensive research and development efforts span a wide array of products, from intermediates and active pharmaceutical ingredients (APIs) to innovative chemical drugs, modern traditional Chinese medicines, biological therapeutics, cellular immunity treatments, and high-end medical devices. These offerings are presented in numerous formulations, including pills, tablets, granules, liquid extracts, powders, syrups, soft capsules, and injectable solutions, as well as health foods. Their therapeutic applications cover vital areas such as antibiotics, gastrointestinal health, and anti-tumor treatments, in addition to specialized medical technologies like cochlear implants. A notable product is Vitamin C for injection, prescribed for conditions including scurvy and idiopathic methemoglobinemia. Beyond its product lines, the firm also provides internet-based medical treatment and other healthcare services. Established in 1965, Hainan Haiyao Co., Ltd. maintains its corporate headquarters in Haikou, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.